iodixanol has been researched along with Carcinoma, Renal Cell in 8 studies
iodixanol: dimeric contrast media; structure given in first source
iodixanol : A dimeric, non-ionic, water-soluble, radiographic contrast agent, used particularly in coronary angiography.
Carcinoma, Renal Cell: A heterogeneous group of sporadic or hereditary carcinoma derived from cells of the KIDNEYS. There are several subtypes including the clear cells, the papillary, the chromophobe, the collecting duct, the spindle cells (sarcomatoid), or mixed cell-type carcinoma.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Image-guided MWA appears to be a safe and effective treatment regardless of nephrometry score and tumor location with high technical success, low recurrence, and complication rates." | 1.51 | The effect of tumor size and location on efficacy and safety of US- and CT- guided percutaneous microwave ablation in renal cell carcinomas. ( Afshari Mirak, S; Ahuja, P; Lu, DS; Mohammadian Bajgiran, A; Pantuck, A; Raman, SS; Shakeri, S; Sisk, A, 2019) |
| "69 patients with metastatic renal cell carcinoma had dynamic contrast-enhanced CT scans at baseline and after 5 and 10 weeks of treatment." | 1.48 | Use of patient outcome endpoints to identify the best functional CT imaging parameters in metastatic renal cell carcinoma patients. ( Donskov, F; Madsen, HHT; Mains, JR; Pedersen, EM; Rasmussen, F; Thorup, K; Thygesen, J, 2018) |
| "CTTA software was used to analyze 20 clear cell renal cell carcinomas (RCCs), 20 papillary RCCs, 20 oncocytomas, and 20 renal cysts." | 1.40 | CT texture analysis of renal masses: pilot study using random forest classification for prediction of pathology. ( Chen, Y; Fishman, EK; Huang, P; Raman, SP; Schroeder, JL, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 8 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mains, JR | 1 |
| Donskov, F | 1 |
| Pedersen, EM | 1 |
| Madsen, HHT | 1 |
| Thygesen, J | 1 |
| Thorup, K | 1 |
| Rasmussen, F | 1 |
| Shakeri, S | 1 |
| Afshari Mirak, S | 1 |
| Mohammadian Bajgiran, A | 1 |
| Pantuck, A | 1 |
| Sisk, A | 1 |
| Ahuja, P | 1 |
| Lu, DS | 1 |
| Raman, SS | 1 |
| Jhaveri, K | 1 |
| Gupta, P | 1 |
| Elmi, A | 1 |
| Flor, L | 1 |
| Moshonov, H | 1 |
| Evans, A | 1 |
| Jewett, M | 1 |
| Bata, P | 1 |
| Tarnoki, DL | 1 |
| Tarnoki, AD | 1 |
| Novak, PK | 1 |
| Gyebnar, J | 1 |
| Kekesi, D | 1 |
| Szendroi, A | 1 |
| Fejer, B | 1 |
| Szasz, AM | 1 |
| Nyirady, P | 1 |
| Karlinger, K | 1 |
| Berczi, V | 1 |
| Raman, SP | 1 |
| Chen, Y | 1 |
| Schroeder, JL | 1 |
| Huang, P | 1 |
| Fishman, EK | 1 |
| Duan, XH | 1 |
| Li, YS | 1 |
| Han, XW | 1 |
| Wang, YL | 1 |
| Jiao, DC | 1 |
| Li, TF | 1 |
| Chen, PF | 1 |
| Fang, Y | 1 |
| Epskamp, C | 1 |
| Snels, DG | 1 |
| Yo, GL | 1 |
| Zuetenhorst, HJ | 1 |
| Hamberg, P | 1 |
| Brookman-May, S | 1 |
| Johannsen, M | 1 |
| May, M | 1 |
| Hoschke, B | 1 |
| Gunschera, J | 1 |
| Wieland, WF | 1 |
| Burger, M | 1 |
8 other studies available for iodixanol and Carcinoma, Renal Cell
| Article | Year |
|---|---|
Use of patient outcome endpoints to identify the best functional CT imaging parameters in metastatic renal cell carcinoma patients.
Topics: Blood Flow Velocity; Blood Volume; Carcinoma, Renal Cell; Contrast Media; Four-Dimensional Computed | 2018 |
The effect of tumor size and location on efficacy and safety of US- and CT- guided percutaneous microwave ablation in renal cell carcinomas.
Topics: Ablation Techniques; Adult; Aged; Aged, 80 and over; Carcinoma, Renal Cell; Contrast Media; Disease | 2019 |
Cystic renal cell carcinomas: do they grow, metastasize, or recur?
Topics: Carcinoma, Renal Cell; Catheter Ablation; Contrast Media; Diagnostic Imaging; Female; Gadolinium DTP | 2013 |
Transitional cell and clear cell renal carcinoma: differentiation of distinct histological types with multiphase CT.
Topics: Aged; Carcinoma, Renal Cell; Carcinoma, Transitional Cell; Contrast Media; Female; Humans; Iohexol; | 2014 |
CT texture analysis of renal masses: pilot study using random forest classification for prediction of pathology.
Topics: Adenoma, Oxyphilic; Aged; Carcinoma, Renal Cell; Contrast Media; Female; Humans; Iohexol; Kidney Dis | 2014 |
C-arm CT-guided renal arterial embolisation followed by radiofrequency ablation for treatment of patients with unresectable renal cell carcinoma.
Topics: Biopsy; Carcinoma, Renal Cell; Catheter Ablation; Combined Modality Therapy; Contrast Media; Emboliz | 2016 |
Bullous fixed drug eruption in a patient with metastatic renal cell carcinoma induced by iodinated contrast during pazopanib treatment.
Topics: Aged; Antineoplastic Agents; Blister; Carcinoma, Renal Cell; Contrast Media; Drug Eruptions; Hand De | 2016 |
Difference between clinical and pathologic renal tumor size, correlation with survival, and implications for patient counseling regarding nephron-sparing surgery.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Renal Cell; Contrast Media; Counseling; Femal | 2011 |